Overview
Chunxia Su practices in Shanghai, China. Su is rated as an Elite expert by MediFind in the treatment of Lung Cancer. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lithotripsy, and Tissue Biopsy.
Their clinical research consists of co-authoring 185 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 149 articles and participated in 1 clinical trial in the study of Lung Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerSu isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- EGFR Positive Lung CancerSu isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaSu isDistinguished. Learn about Lung Adenocarcinoma.
- Advanced
- Small Cell Lung Cancer (SCLC)
- Experienced
- Anal CancerSu isExperienced. Learn about Anal Cancer.
- Bone TumorSu isExperienced. Learn about Bone Tumor.
- Brain TumorSu isExperienced. Learn about Brain Tumor.
- HepatitisSu isExperienced. Learn about Hepatitis.
- Hepatitis BSu isExperienced. Learn about Hepatitis B.
- LithotripsySu isExperienced. Learn about Lithotripsy.